Near future
Contacts
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • energia
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
May 21, 2022

Coronavirus / Russia-Ukraine

Near future

News to understand, anticipate, improve the future.

No Result
View All Result

News to understand, anticipate, improve the future.

Read in:  Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Multiple sclerosis, new immunotherapy in phase 1 studies has stopped her

A promising T-cell-based immunotherapy stops multiple sclerosis: it also appears to reverse its damage, but this needs confirmation.

Gianluca Ricciodi Gianluca Riccio
in Medicine
Share970Pin219Tweet607SendShare170ShareShare121
multiple sclerosis

multiple sclerosis

April 15 2022
⚪ Reads in 2 minutes
A A

In a small phase 1 study, a new immunotherapy that targets cells infected with the Epstein-Barr virus (EBV) managed to stop the progression of multiple sclerosis (MS). That's not all, there is something even more surprising. In some patients, the therapy would have even succeeded in obtaining the remission of symptoms, even if this does not appear fully confirmed in the presentation of the most recent results. I am attaching a PDF document, the report was published in IFL Science.

Big Hunt for Multiple Sclerosis

In recent months, the many researches related to this disease have led to a turning point. In several studies, a correlation between Epstein-Barr virus (EBV) infection and the possible development of multiple sclerosis.

Atara Biotherapeutics has tried to transform these findings into a therapeutic approach to improve the treatment of the disease. And he developed an immunotherapy based on T cells and call ATA188.

Maybe you are also interested

New vaccine for Epstein Barr virus: human experimentation begins

Brain cell transplantation: in mice it cures damage from multiple sclerosis

A compound helps to rebuild myelin in multiple sclerosis patients

multiple sclerosis immunotherapy

How does multiple sclerosis immunotherapy work?

The idea is simple. When EBV-infected cells show small surface proteins known as antigens, immunotherapy supplies and strengthens the immune cells that target and destroy them.

In a study on 24 patients who have received therapy, 20 found improvement or stopping of symptoms. Still, no fatal or serious adverse effects have been reported. 

Some early brain scans show that the therapy may even have "remyelinated" nerve cells, indicating a reversal of the damage caused by multiple sclerosis in the nervous system. As mentioned, however, further confirmation of this hypothesis is needed.

Again, it must be said: the results are extremely promising. However, this is an initial Phase 1 study with a fairly small sample (24 patients) and no placebo or control group. It should be taken with a grain of salt.

Of course, it must be said that this repair is unlikely to occur naturally, so there are very good hopes that the therapy will have really important effects, and we will know more in the next stages of the study.

tags: Multiple sclerosis
Previous post

Which industries will benefit from the robot revolution?

Next Post

CCY-01, the incredible cargo drone from Cyclotech and Yamato

COLLABORATE

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
  • Domus trimaran

    Domus, crazy zero-emission trimaran

    11709 Shares
    Share 4681 Tweet 2926
  • Plastic recycling, shock report: "it doesn't work, and it will never work"

    4355 Shares
    Share 1742 Tweet 1089
  • Create 'renewable' or rather 'perpetual' bio photovoltaic cells

    8233 Shares
    Share 3292 Tweet 2058
  • Hermeus tries it: hypersonic planes of 6000 kilometers per hour

    2350 Shares
    Share 940 Tweet 587
  • Unreal Engine 5, crazy: it doesn't stand out from reality

    5834 Shares
    Share 2333 Tweet 1458

archive

Have a look here:

lift maglev
Technology

Multi, Maglev lift for skyscrapers of the future

Multi allows several cabins to move in blocks using a single compartment. The maglev elevator can run at crazy speeds ...

Read More

Here's how China will take the moon

The office of the future has everything but an office

The astronaut? It is old. Now when you grow up you want to be a youtuber

eat less meat

Do you want to fight climate change? eat less meat.

Next Post
ccy01 one

CCY-01, the incredible cargo drone from Cyclotech and Yamato

The daily tomorrow

Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

Subscribe to our newsletter

Environment
Architecture
Artificial intelligence
Gadgets
concepts
Design

Staff
Archives
Advertising
Privacy Policy

Medicine
Spazio
Robotica
Work
Transportation
energia

To contact the FuturoProssimo editorial team, write to redazione@futuroprossimo.it

Chinese Version
Édition Française
Deutsche Ausgabe
Japanese version
English Edition
Edição Portuguesa
Русское издание
Spanish edition

The daily tomorrow

Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

Chinese Version
Édition Française
Deutsche Ausgabe
Japanese version
English Edition
Edição Portuguesa
Русское издание
Spanish edition

Staff
Archives
Advertising
Privacy Policy

Subscribe to our newsletter

To contact the FuturoProssimo editorial team, write to redazione@futuroprossimo.it

Categories

This work is distributed under license Creative Commons Attribution 4.0 International.
© 2021 Futuroprossimo

No Result
View All Result
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • energia
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
This site uses cookies. By continuing to read it, you consent to their use.